{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:08:01Z","timestamp":1792098481344,"version":"4.4.0"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejpn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.ejpn.2019.12.021","type":"journal-article","created":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T08:46:28Z","timestamp":1578386788000},"page":"47-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"special_numbering":"C","title":["The mitochondrial epilepsies"],"prefix":"10.1016","volume":"24","author":[{"given":"Albert","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhys H.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ejpn.2019.12.021_bib1","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/ana.24362","article-title":"Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease","volume":"77","author":"Gorman","year":"2015","journal-title":"Ann. Neurol."},{"issue":"14 Supplement","key":"10.1016\/j.ejpn.2019.12.021_bib2","article-title":"Phenotypes and genotypes of mitochondrial disease- findings from A national mitochondrial disease cohort (P2.061)","volume":"84","author":"Ng","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2019.12.021_bib3","article-title":"Recent advances in understanding the molecular genetic basis of mitochondrial disease","author":"Thompson","year":"2019","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.ejpn.2019.12.021_bib4","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1750-1172-9-52","article-title":"A\u00a0multicenter study on Leigh syndrome: disease course and predictors of survival","volume":"9","author":"Sofou","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"issue":"7","key":"10.1016\/j.ejpn.2019.12.021_bib5","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/j.1528-1167.2009.02504.x","article-title":"Epileptic phenotypes in children with respiratory chain disorders","volume":"51","author":"El Sabbagh","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejpn.2019.12.021_bib6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.pediatrneurol.2016.08.016","article-title":"Epilepsy characteristics and clinical outcome in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS)","volume":"64","author":"Lee","year":"2016","journal-title":"Pediatr. Neurol."},{"issue":"6","key":"10.1016\/j.ejpn.2019.12.021_bib7","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1212\/WNL.59.6.816","article-title":"Neuronal hyperexcitability in stroke-like episodes of MELAS syndrome","volume":"59","author":"Iizuka","year":"2002","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ejpn.2019.12.021_bib8","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/nan.12238","article-title":"Extensive respiratory chain defects in inhibitory interneurones in patients with mitochondrial disease","volume":"42","author":"Lax","year":"2016","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"2","key":"10.1016\/j.ejpn.2019.12.021_bib9","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/path.4809","article-title":"The genetics and pathology of mitochondrial disease","volume":"241","author":"Alston","year":"2017","journal-title":"J.\u00a0Pathol."},{"issue":"4","key":"10.1016\/j.ejpn.2019.12.021_bib10","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1212\/01.WNL.0000151976.60624.01","article-title":"L-arginine improves the symptoms of strokelike episodes in MELAS","volume":"64","author":"Koga","year":"2005","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ejpn.2019.12.021_bib11","article-title":"Treatment for mitochondrial disorders","author":"Pfeffer","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.ejpn.2019.12.021_bib12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/archneurol.2007.14","article-title":"Juvenile Alpers disease","volume":"65","author":"Wiltshire","year":"2008","journal-title":"Arch. Neurol."},{"issue":"3","key":"10.1016\/j.ejpn.2019.12.021_bib13","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/jnnp.58.3.320","article-title":"Progressive neuronal degeneration of childhood with liver disease (Alpers' disease) presenting in young adults","volume":"58","author":"Harding","year":"1995","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"issue":"21","key":"10.1016\/j.ejpn.2019.12.021_bib14","doi-asserted-by":"crossref","first-page":"9203","DOI":"10.1523\/JNEUROSCI.22-21-09203.2002","article-title":"Barbiturates induce mitochondrial depolarization and potentiate excitotoxic neuronal death","volume":"22","author":"Anderson","year":"2002","journal-title":"J.\u00a0Neurosci."},{"issue":"5","key":"10.1016\/j.ejpn.2019.12.021_bib15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1055\/s-2007-973710","article-title":"Valproate treatment induces lipid globule accumulation with ultrastructural abnormalities of mitochondria in skeletal muscle","volume":"28","author":"Melegh","year":"1997","journal-title":"Neuropediatrics"},{"issue":"Pt 8","key":"10.1016\/j.ejpn.2019.12.021_bib16","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1093\/brain\/awg170","article-title":"Minimum birth prevalence of mitochondrial respiratory chain disorders in children","volume":"126","author":"Skladal","year":"2003","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.ejpn.2019.12.021_bib17","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.pediatrneurol.2008.11.012","article-title":"Pediatric mitochondrial respiratory chain disorders in the Centro region of Portugal","volume":"40","author":"Diogo","year":"2009","journal-title":"Pediatr. Neurol."},{"issue":"3","key":"10.1016\/j.ejpn.2019.12.021_bib18","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/ana.75","article-title":"The incidence of mitochondrial encephalomyopathies in childhood: clinical features and morphological, biochemical, and DNA abnormalities","volume":"49","author":"Darin","year":"2001","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.ejpn.2019.12.021_bib19","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.pediatrneurol.2005.07.011","article-title":"Epidemiology of pediatric mitochondrial respiratory chain disorders in northwest Spain","volume":"34","author":"Castro-Gago","year":"2006","journal-title":"Pediatr. Neurol."},{"issue":"3 Pt 1","key":"10.1016\/j.ejpn.2019.12.021_bib20","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1542\/peds.105.3.598","article-title":"Childhood encephalopathies and myopathies: a prospective study in a defined population to assess the frequency of mitochondrial disorders","volume":"105","author":"Uusimaa","year":"2000","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.ejpn.2019.12.021_bib21","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/ped.12249","article-title":"Molecular diagnosis of mitochondrial respiratory chain disorders in Japan: focusing on mitochondrial DNA depletion syndrome","volume":"56","author":"Yamazaki","year":"2014","journal-title":"Pediatr. Int."},{"issue":"9","key":"10.1016\/j.ejpn.2019.12.021_bib22","first-page":"262","article-title":"Mitochondrial cytopathies, phenotypic heterogeneity and a high incidence","volume":"99","author":"Ryan","year":"2006","journal-title":"Ir. Med. J."},{"issue":"5","key":"10.1016\/j.ejpn.2019.12.021_bib23","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1469-8749.2009.03463.x","article-title":"The clinical presentation of mitochondrial diseases in children with progressive intellectual and neurological deterioration: a national, prospective, population-based study","volume":"52","author":"Verity","year":"2010","journal-title":"Dev. Med. Child Neurol."},{"issue":"4","key":"10.1016\/j.ejpn.2019.12.021_bib24","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/BF01799112","article-title":"Clinical presentation of mitochondrial disorders in childhood","volume":"19","author":"Munnich","year":"1996","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.ejpn.2019.12.021_bib25","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1469-8749.2009.03605.x","article-title":"Mitochondrial diseases in childhood: a clinical approach to investigation and management","volume":"52","author":"Kisler","year":"2010","journal-title":"Dev. Med. Child Neurol."},{"issue":"1","key":"10.1016\/j.ejpn.2019.12.021_bib26","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1055\/s-2008-1076737","article-title":"Epilepsy and respiratory chain defects in children with mitochondrial encephalopathies","volume":"39","author":"Khurana","year":"2008","journal-title":"Neuropediatrics"},{"issue":"4","key":"10.1016\/j.ejpn.2019.12.021_bib27","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1542\/peds.2006-1866","article-title":"Long-term outcome and clinical spectrum of 73 pediatric patients with mitochondrial diseases","volume":"119","author":"Debray","year":"2007","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.ejpn.2019.12.021_bib28","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1542\/peds.2004-0718","article-title":"Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease","volume":"114","author":"Scaglia","year":"2004","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.ejpn.2019.12.021_bib29","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1177\/000992280304200806","article-title":"The clinical spectrum of mitochondrial disease in 75 pediatric patients","volume":"42","author":"Skladal","year":"2003","journal-title":"Clin. Pediatr."},{"issue":"118","key":"10.1016\/j.ejpn.2019.12.021_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003310","article-title":"Molecular diagnosis of infantile mitochondrial disease with targeted next-generation sequencing","volume":"4","author":"Calvo","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"8","key":"10.1016\/j.ejpn.2019.12.021_bib31","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1111\/bph.12469","article-title":"Next-generation sequencing for mitochondrial disorders","volume":"171","author":"Carroll","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.ejpn.2019.12.021_bib32","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S1474-4422(15)00148-9","article-title":"Mitochondrial dysfunction and seizures: the neuronal energy crisis","volume":"14","author":"Zsurka","year":"2015","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.ejpn.2019.12.021_bib33","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ymgme.2007.11.013","article-title":"The unique neuroradiology of complex I deficiency due to NDUFA12L defect","volume":"94","author":"Barghuti","year":"2008","journal-title":"Mol. Genet. Metab."},{"issue":"6","key":"10.1016\/j.ejpn.2019.12.021_bib34","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.ajhg.2009.04.020","article-title":"Mutations in NDUFAF3 (C3ORF60), encoding an NDUFAF4 (C6ORF66)-interacting complex I assembly protein, cause fatal neonatal mitochondrial disease","volume":"84","author":"Saada","year":"2009","journal-title":"Am. J. Hum. Genet."},{"issue":"8","key":"10.1016\/j.ejpn.2019.12.021_bib35","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/hmg\/9.8.1245","article-title":"A\u00a0mutation in the human heme A:farnesyltransferase gene (COX10 ) causes cytochrome c oxidase deficiency","volume":"9","author":"Valnot","year":"2000","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.ejpn.2019.12.021_bib36","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ajhg.2008.08.009","article-title":"FASTKD2 nonsense mutation in an infantile mitochondrial encephalomyopathy associated with cytochrome C oxidase deficiency","volume":"83","author":"Ghezzi","year":"2008","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.ejpn.2019.12.021_bib37","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/jnnp.2005.067041","article-title":"Leigh syndrome caused by mutations in the flavoprotein (Fp) subunit of succinate dehydrogenase (SDHA)","volume":"77","author":"Horvath","year":"2006","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.ejpn.2019.12.021_bib38","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/6772","article-title":"Mutant NDUFV1 subunit of mitochondrial complex I causes leukodystrophy and myoclonic epilepsy","volume":"21","author":"Schuelke","year":"1999","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.ejpn.2019.12.021_bib39","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1086\/301716","article-title":"Demonstration of a new pathogenic mutation in human complex I deficiency: a 5-bp duplication in the nuclear gene encoding the 18-kD (AQDQ) subunit","volume":"62","author":"van den Heuvel","year":"1998","journal-title":"Am. J. Hum. Genet."},{"issue":"6","key":"10.1016\/j.ejpn.2019.12.021_bib40","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1086\/302154","article-title":"The first nuclear-encoded complex I mutation in a patient with Leigh syndrome","volume":"63","author":"Loeffen","year":"1998","journal-title":"Am. J. Hum. Genet."},{"issue":"6","key":"10.1016\/j.ejpn.2019.12.021_bib41","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1111\/j.1528-1167.2008.01877.x","article-title":"Status epilepticus in children with Alpers' disease caused byPOLG1mutations: EEG and MRI features","volume":"50","author":"Wolf","year":"2009","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.ejpn.2019.12.021_bib42","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.nmd.2008.11.014","article-title":"A\u00a0novel homozygous RRM2B missense mutation in association with severe mtDNA depletion","volume":"19","author":"Kollberg","year":"2009","journal-title":"Neuromuscul. Disord."},{"issue":"6","key":"10.1016\/j.ejpn.2019.12.021_bib43","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1086\/430843","article-title":"Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion","volume":"76","author":"Elpeleg","year":"2005","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.ejpn.2019.12.021_bib44","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s10545-011-9413-6","article-title":"Further delineation of pontocerebellar hypoplasia type 6 due to mutations in the gene encoding mitochondrial arginyl-tRNA synthetase","volume":"35","author":"Glamuzina","year":"2011","journal-title":"RARS2 J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.ejpn.2019.12.021_bib45","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1399-0004.2009.01236.x","article-title":"Mutations in the mitochondrial glutamate carrierSLC25A22in neonatal epileptic encephalopathy with suppression bursts","volume":"76","author":"Molinari","year":"2009","journal-title":"Clin. Genet."},{"issue":"6","key":"10.1016\/j.ejpn.2019.12.021_bib46","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1086\/510023","article-title":"Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations","volume":"79","author":"L\u00f3pez","year":"2006","journal-title":"Am. J. Hum. Genet."},{"issue":"5","key":"10.1016\/j.ejpn.2019.12.021_bib47","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ajhg.2009.03.018","article-title":"A\u00a0nonsense mutation in COQ9 causes autosomal-recessive neonatal-onset primary coenzyme Q10 deficiency: a potentially treatable form of mitochondrial disease","volume":"84","author":"Duncan","year":"2009","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.ejpn.2019.12.021_bib48","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ajhg.2007.12.022","article-title":"CABC1 gene mutations cause ubiquinone deficiency with cerebellar ataxia and seizures","volume":"82","author":"Mollet","year":"2008","journal-title":"Am. J. Hum. Genet."},{"issue":"7","key":"10.1016\/j.ejpn.2019.12.021_bib49","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/jcbfm.2013.61","article-title":"Mitochondrial calcium uptake capacity modulates neocortical excitability","volume":"33","author":"Sanganahalli","year":"2013","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"issue":"8","key":"10.1016\/j.ejpn.2019.12.021_bib50","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0165-6147(98)01230-9","article-title":"Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration?","volume":"19","author":"Trotti","year":"1998","journal-title":"Trends Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.ejpn.2019.12.021_bib51","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrm3311","article-title":"AMPK: a nutrient and energy sensor that maintains energy homeostasis","volume":"13","author":"Hardie","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.ejpn.2019.12.021_bib52","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.expneurol.2009.02.014","article-title":"Mitochondrial involvement in temporal lobe epilepsy","volume":"218","author":"Kudin","year":"2009","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.ejpn.2019.12.021_bib53","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jhep.2005.12.026","article-title":"Molecular diagnosis of Alpers syndrome","volume":"45","author":"Nguyen","year":"2006","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.ejpn.2019.12.021_bib54","series-title":"GeneReviews((R))","article-title":"POLG-related disorders","author":"Cohen","year":"1993"},{"issue":"4","key":"10.1016\/j.ejpn.2019.12.021_bib55","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/088307389000500402","article-title":"Progressive neuronal degeneration of childhood with liver disease (Alpers-Huttenlocher syndrome): a personal review","volume":"5","author":"Harding","year":"1990","journal-title":"J.\u00a0Child Neurol."},{"issue":"Pt 7","key":"10.1016\/j.ejpn.2019.12.021_bib56","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1093\/brain\/awl088","article-title":"Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene","volume":"129","author":"Horvath","year":"2006","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.ejpn.2019.12.021_bib57","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/j.1528-1167.2008.01544.x","article-title":"Homozygous W748S mutation in the POLG1 gene in patients with juvenile-onset Alpers syndrome and status epilepticus","volume":"49","author":"Uusimaa","year":"2008","journal-title":"Epilepsia"},{"issue":"10","key":"10.1016\/j.ejpn.2019.12.021_bib58","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1111\/epi.13508","article-title":"Epilepsy due to mutations in the mitochondrial polymerase gamma (POLG) gene: a clinical and molecular genetic review","volume":"57","author":"Anagnostou","year":"2016","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.ejpn.2019.12.021_bib59","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.bbabio.2014.01.021","article-title":"Mapping 136 pathogenic mutations into functional modules in human DNA polymerase gamma establishes predictive genotype-phenotype correlations for the complete spectrum of POLG syndromes","volume":"1837","author":"Farnum","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.ejpn.2019.12.021_bib60","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.pediatrneurol.2012.09.014","article-title":"Alpers-Huttenlocher syndrome","volume":"48","author":"Saneto","year":"2013","journal-title":"Pediatr. Neurol."},{"issue":"4","key":"10.1016\/j.ejpn.2019.12.021_bib61","doi-asserted-by":"crossref","first-page":"Cr203","DOI":"10.12659\/MSM.881716","article-title":"Drug-resistant epilepsia and fulminant valproate liver toxicity. Alpers-Huttenlocher syndrome in two children confirmed post mortem by identification of p.W748S mutation in POLG gene","volume":"17","author":"Pronicka","year":"2011","journal-title":"Med. Sci. Monit."},{"issue":"4","key":"10.1016\/j.ejpn.2019.12.021_bib62","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0887-8994(97)00030-1","article-title":"Valproate-induced liver failure in one of two siblings with Alpers disease","volume":"16","author":"Schwabe","year":"1997","journal-title":"Pediatr. Neurol."},{"issue":"9","key":"10.1016\/j.ejpn.2019.12.021_bib63","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1212\/01.wnl.0000182814.55361.70","article-title":"POLG mutations in Alpers syndrome","volume":"65","author":"Nguyen","year":"2005","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ejpn.2019.12.021_bib64","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ymgme.2012.03.017","article-title":"The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients","volume":"106","author":"Patel","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ejpn.2019.12.021_bib65","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/1750-1172-8-192","article-title":"Mutations in human lipoyltransferase gene LIPT1 cause a Leigh disease with secondary deficiency for pyruvate and alpha-ketoglutarate dehydrogenase","volume":"8","author":"Soreze","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"issue":"Pt 2","key":"10.1016\/j.ejpn.2019.12.021_bib66","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/brain\/awt328","article-title":"Variant non ketotic hyperglycinemia is caused by mutations in LIAS, BOLA3 and the novel gene GLRX5","volume":"137","author":"Baker","year":"2014","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.ejpn.2019.12.021_bib67","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/ana.20818","article-title":"Leigh's disease due to a new mutation in the PDHX gene","volume":"59","author":"Schiff","year":"2006","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.ejpn.2019.12.021_bib68","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.pediatrneurol.2012.09.013","article-title":"Leigh syndrome in a girl with a novel DLD mutation causing E3 deficiency","volume":"48","author":"Quinonez","year":"2013","journal-title":"Pediatr. Neurol."},{"issue":"6","key":"10.1016\/j.ejpn.2019.12.021_bib69","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.ajhg.2011.11.007","article-title":"Thiamine pyrophosphokinase deficiency in encephalopathic children with defects in the pyruvate oxidation pathway","volume":"89","author":"Mayr","year":"2011","journal-title":"Am. J. Hum. Genet."},{"issue":"10","key":"10.1016\/j.ejpn.2019.12.021_bib70","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.braindev.2011.08.003","article-title":"Pyruvate dehydrogenase deficiency and epilepsy","volume":"33","author":"Prasad","year":"2011","journal-title":"Brain Dev."},{"issue":"2","key":"10.1016\/j.ejpn.2019.12.021_bib71","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1469-8749.2009.03541.x","article-title":"Pyruvate dehydrogenase complex deficiency: four neurological phenotypes with differing pathogenesis","volume":"52","author":"BARNERIAS","year":"2010","journal-title":"Dev. Med. Child Neurol."},{"issue":"5","key":"10.1016\/j.ejpn.2019.12.021_bib72","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/ana.20240","article-title":"Ketogenic treatment reduces deleted mitochondrial DNAs in cultured human cells","volume":"56","author":"Santra","year":"2004","journal-title":"Ann. Neurol."},{"issue":"10","key":"10.1016\/j.ejpn.2019.12.021_bib73","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1093\/hmg\/ddq076","article-title":"Ketogenic diet slows down mitochondrial myopathy progression in mice","volume":"19","author":"Ahola-Erkkila","year":"2010","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.ejpn.2019.12.021_bib74","first-page":"957","article-title":"Ketogenic diet attenuates hepatopathy in mouse model of respiratory chain complex III deficiency caused by a Bcs1l mutation","volume":"7","author":"Purhonen","year":"2017"},{"issue":"3","key":"10.1016\/j.ejpn.2019.12.021_bib75","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10545-016-9930-4","article-title":"The pleiotropic effects of decanoic acid treatment on mitochondrial function in fibroblasts from patients with complex I deficient Leigh syndrome","volume":"39","author":"Kanabus","year":"2016","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.ejpn.2019.12.021_bib76","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/ana.24551","article-title":"Leigh syndrome: one disorder, more than 75 monogenic causes","volume":"79","author":"Lake","year":"2016","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.ejpn.2019.12.021_bib77","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/ana.24835","article-title":"Leigh map: a novel computational diagnostic resource for mitochondrial disease","volume":"81","author":"Rahman","year":"2017","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.ejpn.2019.12.021_bib78","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ana.410390311","article-title":"Leigh syndrome: clinical features and biochemical and DNA abnormalities","volume":"39","author":"Rahman","year":"1996","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.ejpn.2019.12.021_bib79","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/jnnp-2012-304426","article-title":"A\u00a0guide to diagnosis and treatment of Leigh syndrome","volume":"85","author":"Baertling","year":"2014","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ejpn.2019.12.021_bib80","first-page":"221","article-title":"The genetics of Leigh syndrome and its implications for clinical practice and risk management","volume":"7","author":"Ruhoy","year":"2014","journal-title":"Appl. Clin. Genet."},{"issue":"2","key":"10.1016\/j.ejpn.2019.12.021_bib81","doi-asserted-by":"crossref","DOI":"10.1007\/s10545-006-0481-y","article-title":"Clinical and molecular survey in 124 Chinese patients with Leigh or Leigh-like syndrome","volume":"30","author":"Zhang","year":"2007","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.ejpn.2019.12.021_bib82","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/gim.2014.104","article-title":"Outcomes of individuals with profound and partial biotinidase deficiency ascertained by newborn screening in Michigan over 25 years","volume":"17","author":"Jay","year":"2015","journal-title":"Genet. Med."},{"issue":"Pt 9","key":"10.1016\/j.ejpn.2019.12.021_bib83","doi-asserted-by":"crossref","first-page":"e295","DOI":"10.1093\/brain\/awu128","article-title":"Infantile Leigh-like syndrome caused by SLC19A3 mutations is a treatable disease","volume":"137","author":"Haack","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.ejpn.2019.12.021_bib84","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.biocel.2014.01.020","article-title":"Coenzyme Q10 as a therapy for mitochondrial disease","volume":"49","author":"Hargreaves","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"8","key":"10.1016\/j.ejpn.2019.12.021_bib85","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/nm.2188","article-title":"Combined treatment with oral metronidazole and N-acetylcysteine is effective in ethylmalonic encephalopathy","volume":"16","author":"Viscomi","year":"2010","journal-title":"Nat. Med."},{"issue":"Pt 4","key":"10.1016\/j.ejpn.2019.12.021_bib86","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1093\/brain\/aww013","article-title":"Liver transplant in ethylmalonic encephalopathy: a new treatment for an otherwise fatal disease","volume":"139","author":"Dionisi-Vici","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.ejpn.2019.12.021_bib87","first-page":"13","article-title":"Thiamine-responsive and non-responsive patients with PDHC-E1 deficiency: a retrospective assessment","volume":"15","author":"van Dongen","year":"2015","journal-title":"JIMD reports"},{"issue":"4","key":"10.1016\/j.ejpn.2019.12.021_bib88","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ymgme.2014.09.010","article-title":"Expanding the clinical and molecular spectrum of thiamine pyrophosphokinase deficiency: a treatable neurological disorder caused by TPK1 mutations","volume":"113","author":"Banka","year":"2014","journal-title":"Mol. Genet. Metab."},{"issue":"22","key":"10.1016\/j.ejpn.2019.12.021_bib89","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1212\/WNL.0b013e318294b44c","article-title":"Phenotypic heterogeneity of the 8344A>G mtDNA \"MERRF\" mutation","volume":"80","author":"Mancuso","year":"2013","journal-title":"Neurology"},{"issue":"s2","key":"10.1016\/j.ejpn.2019.12.021_bib90","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1684\/epd.2016.0861","article-title":"Myoclonus and seizures in progressive myoclonus epilepsies: pharmacology and therapeutic trials","volume":"18","author":"Michelucci","year":"2016","journal-title":"Epileptic Disord."},{"issue":"6","key":"10.1016\/j.ejpn.2019.12.021_bib91","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/ana.24525","article-title":"Epilepsy in adults with mitochondrial disease: a cohort study","volume":"78","author":"Whittaker","year":"2015","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.ejpn.2019.12.021_bib92","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1055\/s-0035-1552624","article-title":"Mitochondrial causes of epilepsy: evaluation, diagnosis, and treatment","volume":"35","author":"Steele","year":"2015","journal-title":"Semin Neurol"},{"issue":"10","key":"10.1016\/j.ejpn.2019.12.021_bib93","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1136\/jmedgenet-2011-100222","article-title":"Mitochondrial DNA polymerase gamma mutations: an ever expanding molecular and clinical spectrum","volume":"48","author":"Tang","year":"2011","journal-title":"J.\u00a0Med. Genet."},{"issue":"1","key":"10.1016\/j.ejpn.2019.12.021_bib94","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/epi4.12094","article-title":"The adjunctive application of transcranial direct current stimulation in the management of de novo refractory epilepsia partialis continua in adolescent-onset POLG-related mitochondrial disease","volume":"3","author":"Ng","year":"2018","journal-title":"Epilepsia open"},{"issue":"5","key":"10.1016\/j.ejpn.2019.12.021_bib95","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/epi.12570","article-title":"Seizure semiology and EEG findings in mitochondrial diseases","volume":"55","author":"Chevallier","year":"2014","journal-title":"Epilepsia"}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379819304416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379819304416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:36:38Z","timestamp":1761071798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379819304416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":95,"alternative-id":["S1090379819304416"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2019.12.021","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The mitochondrial epilepsies","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2019.12.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}